Lassa virus (LV) is a member of the Arenaviridae family and categorized as a hazard group 4 virus by the Advisory Committee on Dangerous Pathogens. These viruses require maximum containment facilities for infectious virus studies. Consequently the virus and the disease have been very poorly researched. This study describes the construction and characterization of recombinant vaccinia viruses expressing LV glycoproteins prepared with two strains of vaccinia virus; Lister and Western Reserve. The LV genome encodes two glycoprotein genes, G1 and G2. Both glycoproteins have been expressed, identified and characterized as being authentic viral proteins using anti-LV human antisera and mouse monoclonal antibodies. To assess if the recombinant vac...
Lassa virus (LASV) is the most prominent human pathogen of the Arenaviridae. The virus is transmitte...
International audienceThe cell entry and humoral immune response of the human pathogen Lassa virus (...
Lassa virus (LASV), a mammarenavirus, infects an estimated 100,000⁻300,000 individuals yearly ...
Lassa virus (LV) is a member of the Arenaviridae family and categorized as a hazard group 4 virus by...
ABSTRACT Lassa virus (LASV) is endemic in Western Africa and is estimated to infect hundreds of thou...
AbstractSeveral viruses in the Arenavirus genus of the family Arenaviridae cause severe, often fatal...
Lassa virus (LASV) is the causative agent of Lassa Fever (LF), an acute and occasionally fatal disea...
<div><p>(A) Left, schematic diagram of the recombinant VSV expressing the glycoprotein of Lassa viru...
AbstractThe Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycopro...
Lassa virus (LASV), the causative agent of Lassa fever, infects several hundred thousand people in W...
Lassa virus is an arenavirus causing a disseminated systemic primary viral infection. This virus cau...
Lassa fever is a viral zoonosis that can be transmitted from person to person, especially in the hos...
Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United ...
Abstract Background Lassa fever is a neglected tropical disease with significant impact on the healt...
AbstractLassa virus (LASV) is a BSL-4 restricted agent. To allow study of infection by LASV under BS...
Lassa virus (LASV) is the most prominent human pathogen of the Arenaviridae. The virus is transmitte...
International audienceThe cell entry and humoral immune response of the human pathogen Lassa virus (...
Lassa virus (LASV), a mammarenavirus, infects an estimated 100,000⁻300,000 individuals yearly ...
Lassa virus (LV) is a member of the Arenaviridae family and categorized as a hazard group 4 virus by...
ABSTRACT Lassa virus (LASV) is endemic in Western Africa and is estimated to infect hundreds of thou...
AbstractSeveral viruses in the Arenavirus genus of the family Arenaviridae cause severe, often fatal...
Lassa virus (LASV) is the causative agent of Lassa Fever (LF), an acute and occasionally fatal disea...
<div><p>(A) Left, schematic diagram of the recombinant VSV expressing the glycoprotein of Lassa viru...
AbstractThe Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycopro...
Lassa virus (LASV), the causative agent of Lassa fever, infects several hundred thousand people in W...
Lassa virus is an arenavirus causing a disseminated systemic primary viral infection. This virus cau...
Lassa fever is a viral zoonosis that can be transmitted from person to person, especially in the hos...
Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United ...
Abstract Background Lassa fever is a neglected tropical disease with significant impact on the healt...
AbstractLassa virus (LASV) is a BSL-4 restricted agent. To allow study of infection by LASV under BS...
Lassa virus (LASV) is the most prominent human pathogen of the Arenaviridae. The virus is transmitte...
International audienceThe cell entry and humoral immune response of the human pathogen Lassa virus (...
Lassa virus (LASV), a mammarenavirus, infects an estimated 100,000⁻300,000 individuals yearly ...